EUVIMEDEUVIMED entdecken
Übersichtsarbeit

Clinicians’ viewpoints on current paradigms of care and research in Parkinson’s disease

Thomas Müller iD, Carsten Buhmann, Martin Delf, Fabian Klostermann, Andreas Kupsch, Axel Lipp, Martina Müngersdorf, Wolfram von Pannwitz, Martin Südmeyer

Journal of Neural Transmission · 2024

DOI: 10.1007/s00702-024-02822-x ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Journal of Neural Transmission, 2024. Verfasst von Thomas Müller und 8 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology, St. Joseph Hospital Berlin-Weissensee, Gartenstr. 1, 13088, Berlin, Germany. th.mueller@alexianer.de. Hauptthemen laut MEDLINE: Parkinson Disease. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 40 Literaturangaben.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Aim of this review is to discuss the value of current ongoing research initiatives in Parkinson's disease from the clinicians' point of view. The repeat, recent failures on progress slowing reflect the drifting apart between initially promising experimental and then disappointing clinical outcomes in the translational trials with well selected Parkinson's disease patients. A similar development concerns the emerging gap between novel developed drugs with improved pharmacokinetic behaviour and their limited use in the clinical practice following approval. Restricted regional different worldwide availability and direct, respectively indirect budget limitations for neurologists in private practice are essential hurdles. They prevent the widespread prescription of these compounds. As a result return of investment for the pharmaceutical industry becomes more and more uncertain. The interest for research on novel treatment approaches for the amelioration of motor and non motor symptoms declines. Clinicians crucially scrutinize the claim for an optimum patient care by payers and regulators.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Parkinson DiseaseHumansAntiparkinson AgentsBiomedical Research

Stichwörter der Autor:innen

CareDiagnosisLevodopaParkinson’s disease

Substanzen

Antiparkinson Agents

Autor:innen und Institutionen

  • Department of Neurology, St. Joseph Hospital Berlin-Weissensee, Gartenstr. 1, 13088, Berlin, Germany. th.mueller@alexianer.de.
  • Department of Neurology, Martinistraße 52, 22051, Hamburg, Germany.
  • Private Practice of Neurology, Lindenallee 7, Dahlwitz-Hoppegarten, 15366, Hoppegarten, Germany.
  • Department of Neurology, Charite, Campus Benjamin Franklin, Hindenburgdamm 30, 12203, Berlin, Germany.
  • Private Practice of Neurology, "Neurologie Bewegt", Bismarckstr 45- 47, Lindenallee 7, 10627, Berlin, Germany.
  • Department of Neurology, Park-Klinik Weißensee, Schönstrasse 80, 13086, Berlin, Germany.

ORCID-Profile: Thomas Müller

Zitieren

APA

Müller, T., Buhmann, C., Delf, M., Klostermann, F., Kupsch, A., Lipp, A., Müngersdorf, M., von Pannwitz, W., & Südmeyer, M. (2024). Clinicians’ viewpoints on current paradigms of care and research in Parkinson’s disease. Journal of Neural Transmission. https://doi.org/10.1007/s00702-024-02822-x

Vancouver

Müller T, Buhmann C, Delf M, Klostermann F, Kupsch A, Lipp A, et al. Clinicians’ viewpoints on current paradigms of care and research in Parkinson’s disease. Journal of Neural Transmission. 2024. doi:10.1007/s00702-024-02822-x

BibTeX
@article{Mller2024,
  author = {Müller, Thomas and Buhmann, Carsten and Delf, Martin and Klostermann, Fabian and Kupsch, Andreas and Lipp, Axel and Müngersdorf, Martina and von Pannwitz, Wolfram and Südmeyer, Martin},
  title = {Clinicians’ viewpoints on current paradigms of care and research in Parkinson’s disease},
  journal = {Journal of Neural Transmission},
  year = {2024},
  doi = {10.1007/s00702-024-02822-x}
}
Kostenlos starten →